Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland
Menu

Louis Boon, PhD
Chief Scientific Officer and Board Member at JJP Biologics
Speaker

Profile

Louis is the CSO and Management Board Member of JJP Biologics, an innovative new Polish Company backed by the Starak family. JJP Biologics develops the next generation of novel therapeutic biologics around personalized medicine and companion diagnostics (JJP Biologics: Overview | LinkedIn). Louis was the founder of various companies focused on the generation and development of therapeutic monoclonal antibodies, primarily in the field of cancer and inflammation. Louis is an author of over 400 publications in international scientific journals in the field of medical biotechnology and an inventor at more than 20 patent applications.

Agenda Sessions

  • Anti-CD89 Antibody for Personalized Treatment of IgA-mediated Inflammatory Disorders

    , 10:20
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See Louis at Antibody Engineering & Therapeutics Europe